Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bodyarmor Rejects NAD’s ‘Upgrade’ Claim Critique

This article was originally published in The Tan Sheet

Executive Summary

Gatorade sports drinks Stokely-Van Camp challenged that Bodyarmor Nutrition was noncompliant with NAD’s April 2014 finding that its ads combined claims that are supported individually in such a way that they created unsupported comparative claims

You may also be interested in...



BodyArmor Rejects NAD Ad Claims Decision Following Gatorade Challenge

BA Sports stands by claims comparing BodyArmor SuperDrink to Gatorade and will not pull or change ads as an industry self-regulation group recommends. Firm's response could draw FTC attention, but previously ignoring the group's recommendations apparently has not prompted FTC enforcement.

Summers Blasts NAD “Secret Rules” After J&J Ointment Claim Challenge

Claims for Summers Labs’ Triple Paste diaper rash ointment spurred Desitin maker Johnson & Johnson to bring a challenge through the National Advertising Division. Summers disagreed with NAD’s conclusion on a physician survey it conducted and declined to discontinue a doctor-recommended claim.

J&J CEO: COVID-19 ‘Demonstrated Importance of Self-Care Overall’

During JP Morgan conference, Alex Gorsky suggests responding to pandemic is changing health care, including businesses providing pharmaceuticals, medical technologies, nutritionals and other necessary products.

Topics

Related Companies

UsernamePublicRestriction

Register

ID1130879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel